Laurie Saint Clair (far right), Director of
Quality and Systems Improvement, American
Heart Association, made the presentation to
Riddle Hospital staff: (L–R) Daphnee Theodore,
Diane Beatty, Dana Fuhrman, Steve Karkenny,
Michelle McLaughlin, Lisa Hall-Sekel and
(Media, PA) - Riddle Hospital, part of Main Line Health, was presented the Get With The Guidelines®-Stroke Gold-Plus Quality Achievement Award for implementing specific quality improvement measures outlined by the American Heart Association/American Stroke Association for treatment of stroke patients. According to the American Heart Association/American Stroke Association, stroke is the number four cause of death and a leading cause of adult disability in the United States. On average, someone suffers a stroke every 40 seconds; someone dies of a stroke every four minutes; and 795,000 people suffer a new or recurrent stroke each year.
The Get With The Guidelines® helps the Riddle Hospital team provide the most up-to-date, research-based guidelines with the goal of speeding recovery and reducing death and disability for stroke patients. By earning the award, Riddle demonstrated their ability to meet specific quality achievement measures for the diagnosis and treatment of stroke patients at a set level for a designated period. These measures include aggressive use of medications and risk-reduction therapies aimed at reducing death and disability and improving the lives of stroke patients.
“We are very proud to have Riddle recognized for the 3rd year in a row by the AHA by receiving the Gold Plus Award for Stroke. I am especially proud of our team members who are so engaged and so focused on providing our patients with timely and effective evidence-based care,” stated Janet M. Webb, Vice President, Administration.
In addition, Riddle received the association’s Target: Stroke Honor Roll for meeting stroke quality measures that reduce the time between hospital arrival and treatment with the clot-buster tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke. People who suffer a stroke who receive the drug within three hours of the onset of symptoms may recover quicker and are less likely to suffer severe disability.